Neutralizing antibodies are the key immune system components at the center of several COVID-19 therapies, including blood plasma transfusions from survivors, vaccines, and monoclonal antibody …
A company announced clinical trial results for a new type of medicine developed specifically to treat the novel coronavirus. Eli Lilly says the data it …
A new type of coronavirus treatment might be ready even before the first vaccine candidates are approved. Monoclonal antibody therapies can be used to treat …
Companies working on brand new coronavirus drugs meant to treat COVID-19 and provide limited immunity are approaching human trials. Monoclonal antibodies are artificially grown antibodies …
